197 related articles for article (PubMed ID: 24884567)
1. Nasal application of neuropeptide S inhibits arthritis pain-related behaviors through an action in the amygdala.
Medina G; Ji G; Grégoire S; Neugebauer V
Mol Pain; 2014 May; 10():32. PubMed ID: 24884567
[TBL] [Abstract][Full Text] [Related]
2. Differential contributions of vasopressin V1A and oxytocin receptors in the amygdala to pain-related behaviors in rats.
Cragg B; Ji G; Neugebauer V
Mol Pain; 2016; 12():. PubMed ID: 27837170
[TBL] [Abstract][Full Text] [Related]
3. Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors.
Palazzo E; Fu Y; Ji G; Maione S; Neugebauer V
Neuropharmacology; 2008 Sep; 55(4):537-45. PubMed ID: 18533199
[TBL] [Abstract][Full Text] [Related]
4. Small-conductance calcium-activated potassium (SK) channels in the amygdala mediate pain-inhibiting effects of clinically available riluzole in a rat model of arthritis pain.
Thompson JM; Ji G; Neugebauer V
Mol Pain; 2015 Aug; 11():51. PubMed ID: 26311432
[TBL] [Abstract][Full Text] [Related]
5. Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain.
Mazzitelli M; Neugebauer V
Neuropharmacology; 2019 Nov; 158():107706. PubMed ID: 31306647
[TBL] [Abstract][Full Text] [Related]
6. Monomethyl fumarate inhibits pain behaviors and amygdala activity in a rat arthritis model.
Kim H; Thompson J; Ji G; Ganapathy V; Neugebauer V
Pain; 2017 Dec; 158(12):2376-2385. PubMed ID: 28832396
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviors.
Ren W; Kiritoshi T; Grégoire S; Ji G; Guerrini R; Calo G; Neugebauer V
J Neurophysiol; 2013 Oct; 110(8):1765-81. PubMed ID: 23883857
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2CR blockade in the amygdala conveys analgesic efficacy to SSRIs in a rat model of arthritis pain.
Grégoire S; Neugebauer V
Mol Pain; 2013 Aug; 9():41. PubMed ID: 23937887
[TBL] [Abstract][Full Text] [Related]
9. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior.
Fu Y; Neugebauer V
J Neurosci; 2008 Apr; 28(15):3861-76. PubMed ID: 18400885
[TBL] [Abstract][Full Text] [Related]
10. mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain.
Han JS; Neugebauer V
Pain; 2005 Jan; 113(1-2):211-22. PubMed ID: 15621382
[TBL] [Abstract][Full Text] [Related]
11. Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain.
Li W; Neugebauer V
Pain; 2004 Jul; 110(1-2):112-22. PubMed ID: 15275758
[TBL] [Abstract][Full Text] [Related]
12. Spinal CGRP1 receptors contribute to supraspinally organized pain behavior and pain-related sensitization of amygdala neurons.
Adwanikar H; Ji G; Li W; Doods H; Willis WD; Neugebauer V
Pain; 2007 Nov; 132(1-2):53-66. PubMed ID: 17335972
[TBL] [Abstract][Full Text] [Related]
13. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala.
Ji G; Fu Y; Ruppert KA; Neugebauer V
Mol Pain; 2007 Jun; 3():13. PubMed ID: 17550594
[TBL] [Abstract][Full Text] [Related]
14. Small conductance calcium activated potassium (SK) channel dependent and independent effects of riluzole on neuropathic pain-related amygdala activity and behaviors in rats.
Thompson JM; Yakhnitsa V; Ji G; Neugebauer V
Neuropharmacology; 2018 Aug; 138():219-231. PubMed ID: 29908238
[TBL] [Abstract][Full Text] [Related]
15. PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior.
Fu Y; Han J; Ishola T; Scerbo M; Adwanikar H; Ramsey C; Neugebauer V
Mol Pain; 2008 Jul; 4():26. PubMed ID: 18631385
[TBL] [Abstract][Full Text] [Related]
16. Intra-amygdala microinfusion of neuropeptide S attenuates neuropathic pain and suppresses the response of spinal microglia and astrocytes after spinal nerve ligation in rats.
Yang F; Peng L; Luo J; Yi H; Hu X
Peptides; 2016 Aug; 82():26-34. PubMed ID: 27224019
[TBL] [Abstract][Full Text] [Related]
17. Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain.
Li W; Neugebauer V
J Neurophysiol; 2006 Oct; 96(4):1803-15. PubMed ID: 16760343
[TBL] [Abstract][Full Text] [Related]
18. Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects.
Lukas M; Neumann ID
Neuropharmacology; 2012 Jan; 62(1):398-405. PubMed ID: 21871467
[TBL] [Abstract][Full Text] [Related]
19. Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior.
Han JS; Li W; Neugebauer V
J Neurosci; 2005 Nov; 25(46):10717-28. PubMed ID: 16291945
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala.
Ji G; Neugebauer V
J Neurophysiol; 2007 Jun; 97(6):3893-904. PubMed ID: 17392412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
